Anna Ruiz Llobet
Investigador
Research group
Anna Ruiz Llobet graduated in Medicine from the University of Navarra in 2004. After completing the MIR training in the speciality of Paediatrics, she completed her training with the Master in Paediatric Haematology offered by the University of Barcelona -Hospital San Juan de Dios Barcelona in 2011.
In 2015, she joined the Haematology Service of the Sant Joan de Déu Barcelona Hospital as a specialist doctor.
Currently, the research group of paediatric leukaemia and hemopathies participates. This group is dedicated to translational research, aimed at applying the new knowledge regarding the pathophysiology and diagnosis of these diseases to healthcare practice in order to offer personalized treatment for affected patients.
SJD Barcelona Children's Hospital Last Publications
- Velasco Puyo P, Christou S, Campisi S, Rodríguez-Sánchez MA, Reidel S, Perez-Hoyo S, Mota M, Savvidou I, Rekleiti A, Salvo A, Voi V, Ferrero GB, Mandrile G, Gaglioti CM, Cela E, Ponce-Salas B, Bardón-Cancho EJ, Flevari P, Voskaridou-Dimoula E, Nur E, Biemond BJ, Delaporta P, Beneitez-Pastor D, Collado Gimbert A, Spasiano A, Besse-Hammer T, Lafiatis IG, Dedeken L, Raso S, Ruiz-Llobet A, Bagnato S, Labarque V, Glenthøj A, Ruffo GB, Guerzoni ME, Hafraoui K, Pistoia L, Rosso R, Tagliaferri L, Gonzalez-Urdiales P, Benghiat FS, de Montalembert M, Teles MJ, Vanderfaeillie A, Bertoni E, Cuzzubbo D, Ferreira T, Saunders CJ, Stiakaki E, Van de Velde AL, Diamantidis MD, Kerkhoffs JH, Oliveira MI, Quota A, Russo R, Van Damme A, Argüello Marina M, Lorite Reggiori M, Rijneveld AW, Rodríguez Gallego A, Colombatti R, Iolascon A, Taher A, Gulbis B, Roy NBA and Mañú-Pereira MDM COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet ORPHANET JOURNAL OF RARE DISEASES . 20(1): 183-183.
- González de Aledo-Castillo JM, Argudo-Ramírez A, Beneitez-Pastor D, Collado-Gimbert A, Almazán Castro F, Roig-Bosch S, Andrés-Masó A, Ruiz-Llobet A, Pedrals-Portabella G, Medina-Santamaria D, Nadal-Rey G, Espigares-Salvia M, Coll-Sibina MT, Algar-Serrano M, Torrent-Español M, Leoz-Allegretti P, Rodríguez-Pebé A, García-Bernal M, Solà-Segura E, García-Gallego A, Prats-Viedma B, López-Galera RM, Paredes-Fuentes AJ, Pajares García S, Delgado-López G, Blanco-Álvarez A, Tazón-Vega B, Díaz de Heredia C, Mañú-Pereira MDM, Marín-Soria JL, García-Villoria J, Velasco-Puyó P and On Behalf Of The Sickle Cell Disease Newborn Screening Group Of Catalonia Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022-Epidemiology and Impact on Clinical Events. International Journal of Neonatal Screening . 10(4): .
- Ruiz-Llobet A, Gassiot S, Sarrate E, Zubicaray J, Rives-Solà S, Suleman W and Berrueco R Thrombin Generation Profile Using ST-Genesia after PEG-asparaginase in Pediatric Patients with Acute Lymphoblastic Leukemia THROMBOSIS AND HAEMOSTASIS . 124(10): 973-985.
Projects
- Project name:
- Tratamiento y prevención de la coagulopatía intravascular localizada en malformaciones venosas y linfáticas de bajo flujo en pacientes pediátricos. Uso de enoxaparina durante intervencionismo percutáneo
- Leader
- Eulalia Baselga Torres
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI24/00803
- Starting - finishing date:
- 2025 - 2027
- Project name:
- Hacia la personalización de la profilaxis de la trombosis venosa profunda en pacientes pediátricos afectos de leucemia linfoblástica aguda: uso de test de generación de trombina.
- Leader
- Ruben Berrueco Moreno
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- PI17/00356
- Starting - finishing date:
- 2018 - 2022